PREMATURE OVARIAN FAILURE 7 (disorder)
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
PREMATURE OVARIAN FAILURE 7 (disorder)
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
PREMATURE OVARIAN FAILURE 7 (disorder)
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
SPERMATOGENIC FAILURE 8
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
SPERMATOGENIC FAILURE 8
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
SPERMATOGENIC FAILURE 8
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
46,XY Sex Reversal 3
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
46,XY Sex Reversal 3
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Gonadal Dysgenesis, 46,XX
|
0.510 |
GeneticVariation
|
disease |
BEFREE |
Preserved fertility in a patient with a 46,XY disorder of sex development due to a new heterozygous mutation in the NR5A1/SF-1 gene: evidence of 46,XY and 46,XX gonadal dysgenesis phenotype variability in multiple members of an affected kindred.
|
22907560 |
2012 |
Gonadal Dysgenesis, 46,XX
|
0.510 |
Biomarker
|
disease |
CTD_human |
Mutations in NR5A1 associated with ovarian insufficiency.
|
19246354 |
2009 |
Gonadal Dysgenesis, 46,XX
|
0.510 |
GermlineCausalMutation
|
disease |
ORPHANET |
|
|
|
Adrenal gland hypofunction
|
0.500 |
GeneticVariation
|
phenotype |
BEFREE |
In rare cases, sequence variants of the NR5A1/SF-1 gene may result in POI, or in various disorders of gonadal development (DGD) or adrenal insufficiency.
|
31831369 |
2019 |
Adrenal gland hypofunction
|
0.500 |
GeneticVariation
|
phenotype |
BEFREE |
Several mutations in NR5A1 have been reported to cause gonadal dysgenesis with adrenal insufficiency in individuals with 46,XY karyotype.
|
29265478 |
2018 |
Adrenal gland hypofunction
|
0.500 |
Biomarker
|
phenotype |
BEFREE |
A Novel Mutation in the Critical P-Box Residue of Steroidogenic Factor-1 Presenting with XY Sex Reversal and Transient Adrenal Failure.
|
29151085 |
2018 |
Adrenal gland hypofunction
|
0.500 |
GeneticVariation
|
phenotype |
BEFREE |
In this report, we describe a novel heterozygous c.814A > C (p. T272P) NR5A1 mutation in a patient with 46, XY DSD without adrenal insufficiency.
|
27135758 |
2017 |
Adrenal gland hypofunction
|
0.500 |
GeneticVariation
|
phenotype |
BEFREE |
Novel Heterozygous Mutations of NR5A1 and Their Functional Characteristics in Patients with 46,XY Disorders of Sex Development without Adrenal Insufficiency.
|
26139438 |
2015 |
Adrenal gland hypofunction
|
0.500 |
GeneticVariation
|
phenotype |
BEFREE |
This is the first study searching for NR5A1 mutations in oriental patients from the Middle East and Arab region with XY DSD and no adrenal insufficiency, revealing a frequency similar to that in European patients (6.5-15%).
|
24591553 |
2014 |
Adrenal gland hypofunction
|
0.500 |
GeneticVariation
|
phenotype |
BEFREE |
Mutations in the NR5A1 gene (SF-1) were previously described in disorders of sexual development and adrenal insufficiency.
|
22100173 |
2012 |
Adrenal gland hypofunction
|
0.500 |
Biomarker
|
phenotype |
BEFREE |
Consequently, initial work on the potential effects of SF-1 disruption in humans focused on individuals with primary adrenal failure, a 46,XY karyotype, complete gonadal dysgenesis, and Müllerian structures.
|
23044873 |
2012 |
Adrenal gland hypofunction
|
0.500 |
GeneticVariation
|
phenotype |
BEFREE |
NR5A1 mutations have been identified in patients with various forms of 46,XY disorders of sex development (DSD), including complete gonadal dysgenesis with or without adrenal insufficiency, mild testicular dysgenesis with ambiguous external genitalia or female external genitalia with clitoromegaly, and penoscrotal hypospadias.
|
21654157 |
2011 |
Adrenal gland hypofunction
|
0.500 |
GeneticVariation
|
phenotype |
BEFREE |
More recently, heterozygous NR5A1 mutations have been identified in a substantial proportion of patients with 46,XY disorders of sex development (46,XY DSD) without adrenal insufficiency.
|
20595937 |
2010 |
Adrenal gland hypofunction
|
0.500 |
GeneticVariation
|
phenotype |
BEFREE |
Recently, heterozygous mutations in the NR5A1 gene (nuclear receptor subfamily 5, group A, member 1; MIM +184757) have been described in association with ovarian failure and disorders of testis development with or without adrenal failure.
|
20453312 |
2010 |
Adrenal gland hypofunction
|
0.500 |
Biomarker
|
phenotype |
BEFREE |
The spectrum of phenotypes associated with mutations in steroidogenic factor 1 (SF-1, NR5A1, Ad4BP) includes severe penoscrotal hypospadias in 46,XY males without adrenal insufficiency.
|
19439508 |
2009 |
Adrenal gland hypofunction
|
0.500 |
GeneticVariation
|
phenotype |
BEFREE |
In conclusion, we add a novel mutation of NR5A1 in 46, XY DSD patient without adrenal failure.
|
19318730 |
2009 |
Pure Gonadal Dysgenesis, 46, XX
|
0.500 |
Biomarker
|
disease |
CTD_human |
Mutations in NR5A1 associated with ovarian insufficiency.
|
19246354 |
2009 |